About Department of Ophthalmology, Mount Sinai School of Medicine
Clinical Trials at Department of Ophthalmology, Mount Sinai School of Medicine
During the past decade, Department of Ophthalmology, Mount Sinai School of Medicine conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Ophthalmology, Mount Sinai School of Medicine"
#1 collaborator was "National Eye Institute (NEI)" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Department of Ophthalmology, Mount Sinai School of Medicine
According to Clinical.Site data, the most researched conditions in "Department of Ophthalmology, Mount Sinai School of Medicine" are
"Diabetic Macular Edema" (2 trials), "Cytomegalovirus Retinitis" (1 trials), "HIV Infections" (1 trials), "Intraocular Inflammation" (1 trials) and "Proliferative Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "Department of Ophthalmology, Mount Sinai School of Medicine" in a lesser frequency.
Clinical Trials Intervention Types at Department of Ophthalmology, Mount Sinai School of Medicine
Most popular intervention types in "Department of Ophthalmology, Mount Sinai School of Medicine" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Infliximab (intravitreal, 2.0mg/0.05ml)" (2 trials), "0.3 mg intravitreal ranibizumab" (1 trials), "1.25 mg intravitreal bevacizumab" (1 trials), "2.0 mg intravitreal aflibercept" (1 trials) and "Cidofovir intravenous" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Department of Ophthalmology, Mount Sinai School of Medicine
The vast majority of trials in "Department of Ophthalmology, Mount Sinai School of Medicine" are
5 trials for "All" genders.
Clinical Trials Status at Department of Ophthalmology, Mount Sinai School of Medicine
Currently, there are NaN active trials in "Department of Ophthalmology, Mount Sinai School of Medicine".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Department of Ophthalmology, Mount Sinai School of Medicine,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Department of Ophthalmology, Mount Sinai School of Medicine, 2 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".